These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38195949)

  • 1. Genetics of primary hyperparathyroidism, our first Batrinos' scholar review, metabolic syndrome, and quite a bit of reproductive endocrinology: a great issue.
    Stratakis CA
    Hormones (Athens); 2024 Mar; 23(1):1-2. PubMed ID: 38195949
    [No Abstract]   [Full Text] [Related]  

  • 2. Italian Society of Endocrinology Consensus Statement: definition, evaluation and management of patients with mild primary hyperparathyroidism.
    Marcocci C; Brandi ML; Scillitani A; Corbetta S; Faggiano A; Gianotti L; Migliaccio S; Minisola S
    J Endocrinol Invest; 2015 May; 38(5):577-93. PubMed ID: 25820553
    [No Abstract]   [Full Text] [Related]  

  • 3. Emerging data on cardiovascular risk in primary hyperparathyroidism.
    Pepe J; Piemonte S; Cipriani C; Cilli M; Minisola S
    Endocrine; 2014 Nov; 47(2):345-7. PubMed ID: 25205449
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyperparathyroidism and the general paediatrician.
    Cheetham T; Bliss R
    Arch Dis Child; 2015 Oct; 100(10):904-5. PubMed ID: 26141539
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter to the editor: Distinguishing typical primary hyperparathyroidism from familial hypocalciuric hypercalcemia by using an index of urinary calcium.
    Marx SJ
    J Clin Endocrinol Metab; 2015 Feb; 100(2):L29-30. PubMed ID: 25658165
    [No Abstract]   [Full Text] [Related]  

  • 6. ENDOCRINOPATHIES AND PEPTIC ULCER.
    GRAY SJ
    Am J Dig Dis; 1964 Apr; 9():279-84. PubMed ID: 14142390
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter to the editor: Thiazides are not inducers of PTH secretion: a comment on normocalcemic hyperparathyroidism.
    Yacobi-Bach M; Serebro M; Greenman Y; Tordjman K; Stern N
    J Clin Endocrinol Metab; 2015 Feb; 100(2):L27-8. PubMed ID: 25658164
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary hyperparathyroidism clinical features on endocrinology in-patients clinic.
    Sapozhnikova IE
    Ter Arkh; 2018 Nov; 90(10):51-54. PubMed ID: 30701796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. METABOLIC DISORDERS AFFECTING THE JAW.
    COHEN B
    J Oral Surg Anesth Hosp Dent Serv; 1964 Mar; 22():103-9. PubMed ID: 14130140
    [No Abstract]   [Full Text] [Related]  

  • 10. [Endocrinology 2009].
    Harbeck B; Mönig H; Lehnert H
    Dtsch Med Wochenschr; 2009 Jun; 134(25-26):1361-6. PubMed ID: 19517332
    [No Abstract]   [Full Text] [Related]  

  • 11. [The latest developments in endocrinology 2004/2005].
    Fottner C; Weber MM
    Med Klin (Munich); 2006 Jan; 101(1):29-36. PubMed ID: 16418812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Normocalcemic primary hyperparathyroidism: recommendations for management and follow-up].
    Martínez Díaz-Guerra G; Jódar Gimeno E; Reyes García R; Gómez Sáez JM; Muñoz-Torres M;
    Endocrinol Nutr; 2013 Oct; 60(8):456.e1-6. PubMed ID: 23660008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [News in endocrinology: Management of asymptomatic primary hyperparathyroidism in 2014].
    Köhler BB; Philippe J
    Rev Med Suisse; 2015 Jan; 11(456-457):58-61. PubMed ID: 25799652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymptomatic and normocalcemic hyperparathyroidism, the silent attack: a combo-endocrinology overview.
    Anastasilakis DA; Makras P; Polyzos SA; Anastasilakis AD;
    Hormones (Athens); 2019 Mar; 18(1):65-70. PubMed ID: 30255479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HYDROXYPROLINE EXCRETION IN ENDOCRINE DISEASE.
    BENOIT FL; THEIL GB; WATTEN RH
    Metabolism; 1963 Dec; 12():1072-82. PubMed ID: 14100279
    [No Abstract]   [Full Text] [Related]  

  • 16. MECHANISMS IN ENDOCRINOLOGY: Kidney involvement in patients with primary hyperparathyroidism: an update on clinical and molecular aspects.
    Verdelli C; Corbetta S
    Eur J Endocrinol; 2017 Jan; 176(1):R39-R52. PubMed ID: 27601015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Key developments in endocrinology.
    Mistry D; Maung KH; Manuchehri AM; Sathyapalan T; Atkin S; England J
    Practitioner; 2005 Aug; 249(1673):541, 543-7, 549 passim. PubMed ID: 16108472
    [No Abstract]   [Full Text] [Related]  

  • 18. Note by Hormones' new editor: metabolic syndrome plus obesity and COVID-19, the two concurrent pandemics and the field of endocrinology.
    Stratakis CA
    Hormones (Athens); 2022 Sep; 21(3):347-348. PubMed ID: 35997948
    [No Abstract]   [Full Text] [Related]  

  • 19. [Primary hyperparathyroidism: new concepts, new recommendations].
    Crouzeix G; Kerlan V
    Ann Endocrinol (Paris); 2014 Oct; 75 Suppl 1():S21-36. PubMed ID: 25617920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National survey on the management of primary hyperparathyroidism by Swiss endocrinologists.
    Clerici T; Warschkow R; Triponez F; Brändle M
    Langenbecks Arch Surg; 2007 Sep; 392(5):611-5. PubMed ID: 17294209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.